The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin.

Source:http://linkedlifedata.com/resource/pubmed/id/20190202

Download in:

View as

General Info

PMID
20190202